Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 28 | Neagle MatthewChief Operating Officer |  PRCHPorch Group, Inc.Open-market sale | SELL | $449K 62.8K sh | Apr 10, 2026 |
| 27 | Stout Jay SChief Technology Officer |  IMVTImmunovant, Inc.Open-market sale | SELL | $38K 1,518 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 27 | Gold JudithDirector |  RSIRush Street Interactive, Inc.Open-market sale · 10b5-1 plan | SELL | $39K 1,714 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $340K 22.6K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $219K 2,400 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $237K 2,600 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $55K 600 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 700 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 25 | Mindlin Damian MiguelVice President |  PAMPampa Energy Inc.Open-market sale | SELL | $200K 57.5K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 23 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1,288 14 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 23 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,340 100 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 23 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,340 100 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 22 | Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER |  WHWKWhitehawk Therapeutics, Inc.Open-market sale | SELL | $49K 14.5K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 22 | Rezvan MitraChief Accounting Officer |  SAILSailPoint, Inc.Open-market sale · 10b5-1 plan | SELL | $21K 1,683 sh | Apr 10, 2026 traded Apr 7, 2026 |
| 22 | Tabak ShawnCHIEF FINANCIAL OFFICER | PRCHPorch Group, Inc. Open-market sale | SELL | $55K 7,734 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 19 | Robins Harlan SChief Scientific Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $149K 10.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 18 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $1.13M 1,956 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 18 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $1.02M 1,756 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 17 | McCallion Kevin J.SVP, Products and Production |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $131K 18.6K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Van Well DaanChief Legal Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $9,424 1,988 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Papadopoulos DidierPresident of Aircraft OEM |  JOBYJoby Aviation, Inc.Open-market sale · 10b5-1 plan | SELL | $2,295 271 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,786 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,239 1,950 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,244 1,950 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,861 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Rezvan MitraChief Accounting Officer | SAILSailPoint, Inc. Open-market sale · 10b5-1 plan | SELL | $22K 1,681 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Cardoza GeorgeChief Financial Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $6,801 1,403 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,800 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Rezvan MitraChief Accounting Officer | SAILSailPoint, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 3,310 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Rezvan MitraChief Accounting Officer | SAILSailPoint, Inc. Open-market sale · 10b5-1 plan | SELL | $1,978 162 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,800 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,152 1,931 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Clark Joseph GatesSVP and Pres, Optimized LED |  PENGPenguin Solutions, Inc.Open-market sale · 10b5-1 plan | SELL | $283K 12.5K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Yeh Kuanling AmyChief Technology Officer | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 3,000 sh | Apr 10, 2026 traded Apr 10, 2026 |
| 16 | Savitz RyanEVP, CFO & CBO |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $739K 8,224 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,176 1,936 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,800 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Valente ManuelaChief People Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $19K 3,824 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $1.25M 8,100 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 15 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $934K 1,617 sh | Apr 10, 2026 traded Apr 9, 2026 |